Clinical Trials Browser

Phase 1/2 × Withdrawn × Other solid neoplasm × Clear all

NCT05982522 2026-03-27

IN10018 Combination Therapy in Previously-treated Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT03973333 2024-10-18

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Phase 1/2 Withdrawn

Other solid neoplasm

Select Advanced Solid Tumors

NCT06090318 2023-10-19

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Phase 1/2 Withdrawn

DermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Melanoma, Mesothelioma, Stomach Neoplasms

NCT03427320 2022-07-11

Imaging of Advanced Tumours Using [131]I-IAZA

Phase 1/2 Withdrawn

Other solid neoplasm

Locally Advanced Solid Tumors

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT05177276 2022-01-04

Selinexor Combination Ph 1 Study

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor Malignancy

NCT02661100 2016-12-07

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Phase 1/2 Withdrawn

DermatologicOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Mesothelioma, Neoplasms, Small Cell Lung Carcinoma

NCT00668499 2014-05-21

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Phase 1/2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma

NCT01353482 2012-03-22

MESO-02

Phase 1/2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT00148993 2011-04-08

Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Metastatic Solid Tumors